| Therapeutic developments in pancreatic cancer: current and future perspectives JP Neoptolemos, J Kleeff, P Michl, E Costello, W Greenhalf, DH Palmer Nature reviews Gastroenterology & hepatology 15 (6), 333-348, 2018 | 921 | 2018 |
| Stromal biology and therapy in pancreatic cancer A Neesse, P Michl, KK Frese, C Feig, N Cook, MA Jacobetz, MP Lolkema, ... Gut 60 (6), 861-868, 2011 | 891 | 2011 |
| Expression of leptin receptor isoforms in rat brain microvessels C Bjørbæk, JK Elmquist, P Michl, RS Ahima, A Van Bueren, AL McCall, ... Endocrinology 139 (8), 3485-3491, 1998 | 496 | 1998 |
| Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer P Michl, C Barth, M Buchholz, MM Lerch, M Rolke, KH Holzmann, ... Cancer research 63 (19), 6265-6271, 2003 | 370 | 2003 |
| Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin P Michl, M Buchholz, M Rolke, S Kunsch, M Löhr, B McClane, S Tsukita, ... Gastroenterology 121 (3), 678-684, 2001 | 370 | 2001 |
| Overexpression of c‐myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway M Buchholz, A Schatz, M Wagner, P Michl, T Linhart, G Adler, TM Gress, ... The EMBO journal 25 (15), 3714-3724, 2006 | 349 | 2006 |
| Stromal biology and therapy in pancreatic cancer: ready for clinical translation? A Neesse, CA Bauer, D Öhlund, M Lauth, M Buchholz, P Michl, ... Gut 68 (1), 159-171, 2019 | 312 | 2019 |
| WNT5A—target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer S Ripka, A König, M Buchholz, M Wagner, B Sipos, G Klöppel, ... Carcinogenesis 28 (6), 1178-1187, 2007 | 245 | 2007 |
| S3-guideline exocrine pancreatic cancer T Seufferlein, M Porzner, T Becker, V Budach, G Ceyhan, I Esposito, ... Zeitschrift fur Gastroenterologie 51 (12), 1395-1440, 2013 | 231 | 2013 |
| CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness P Michl, AR Ramjaun, OE Pardo, PH Warne, M Wagner, R Poulsom, ... Cancer cell 7 (6), 521-532, 2005 | 221 | 2005 |
| Current concepts and novel targets in advanced pancreatic cancer P Michl, TM Gress Gut 62 (2), 317-326, 2013 | 204 | 2013 |
| Evidence-based diagnosis and staging of pancreatic cancer P Michl, S Pauls, TM Gress Best practice & research Clinical gastroenterology 20 (2), 227-251, 2006 | 202 | 2006 |
| Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer J Ellermeier, J Wei, P Duewell, S Hoves, MR Stieg, T Adunka, ... Cancer research 73 (6), 1709-1720, 2013 | 189 | 2013 |
| Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia RJ Schauer, AL Gerbes, D Vonier, H Meissner, P Michl, R Leiderer, ... Annals of surgery 239 (2), 220-231, 2004 | 173 | 2004 |
| The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited … SE Al-Batran, TO Goetze, DW Mueller, A Vogel, M Winkler, S Lorenzen, ... BMC cancer 17, 1-7, 2017 | 169 | 2017 |
| Desmoplasia and chemoresistance in pancreatic cancer M Schober, R Jesenofsky, R Faissner, C Weidenauer, W Hagmann, ... Cancers 6 (4), 2137-2154, 2014 | 167 | 2014 |
| Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines CK Weber, G Sommer, P Michl, H Fensterer, M Weimer, F Gansauge, ... Gastroenterology 121 (3), 657-667, 2001 | 161 | 2001 |
| Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers P Michl, J Downward Zeitschrift für Gastroenterologie 43 (10), 1133-1139, 2005 | 143 | 2005 |
| CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer S Ripka, A Neesse, J Riedel, E Bug, A Aigner, R Poulsom, S Fulda, ... Gut 59 (8), 1101-1110, 2010 | 128 | 2010 |
| Multiple myeloma cells are protected against dexamethasone‐induced apoptosis by insulin‐like growth factors F Xu, A Gardner, Y Tu, P Michl, D Prager, A Lichtenstein British journal of haematology 97 (2), 429-440, 1997 | 128 | 1997 |
